Literature DB >> 11433432

Cysteine dioxygenase: regional localisation of protein and mRNA in rat brain.

R B Parsons1, R H Waring, A C Williams, D B Ramsden.   

Abstract

Cysteine dioxygenase (CDO) converts cysteine to cysteinesulphinic acid and is the rate-limiting step in sulphate production. Most studies have centred upon the hepatic form of the enzyme, but several studies have investigated brain CDO using activity assays and western blotting. The aim of this study was to investigate the expression of CDO in the rat brain using a combination of immunohistochemistry and in situ hybridisation. Affinity-purified anti-R and anti-H CDO antibodies were immunoprecipitated using rat brain homogenate to determine whether the antibodies could remove enzyme activity. Immunohistochemistry and in situ hybridisation were then used to determine the cellular and regional expression of both CDO protein and mRNA. Immunoprecipitation of rat brain homogenate removed up to 98% and 70% (anti-R and anti-H, respectively) of enzyme activity. Nonimmune sheep serum had no effect upon enzyme activity. CDO protein and mRNA was localised solely to the neurones of the brain, including the pyramidal cells of the hippocampus and the Purkinje cells of the cerebellum. Regional localisation varied, with high levels of expression in the hippocampus, the dentate gyrus, the outer cortices of the brain, and the substantia nigra. The relative expression of CDO activity and protein in these regions is most probably a result of the relative abundance of neurones in these regions. CDO expression in the brain may have several possibilities functions, the most likely being the prevention of free radical production by the autoxidation of cysteine and dopamine. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11433432     DOI: 10.1002/jnr.1130

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Measurement of Cysteine Dioxygenase Activity and Protein Abundance.

Authors:  Martha H Stipanuk; John E Dominy; Iori Ueki; Lawrence L Hirschberger
Journal:  Curr Protoc Toxicol       Date:  2008-11-01

2.  A prospective study of transsulfuration biomarkers in autistic disorders.

Authors:  David A Geier; Janet K Kern; Carolyn R Garver; James B Adams; Tapan Audhya; Mark R Geier
Journal:  Neurochem Res       Date:  2008-07-09       Impact factor: 3.996

Review 3.  Building biosynthetic schools: reviewing compartmentation of CNS taurine synthesis.

Authors:  John Dominy; Stephanie Eller; Ralph Dawson
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 4.  Role of the liver in regulation of body cysteine and taurine levels: a brief review.

Authors:  Martha H Stipanuk
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 5.  Cysteine dioxygenase: a robust system for regulation of cellular cysteine levels.

Authors:  M H Stipanuk; I Ueki; J E Dominy; C R Simmons; L L Hirschberger
Journal:  Amino Acids       Date:  2008-11-15       Impact factor: 3.520

6.  Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth.

Authors:  Antony Prabhu; Bhaswati Sarcar; Soumen Kahali; Zhigang Yuan; Joseph J Johnson; Klaus-Peter Adam; Elizabeth Kensicki; Prakash Chinnaiyan
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.